Diabetic Nephropathy Industry

New York, Oct. 19, 2023 (GLOBE NEWSWIRE) -- In 2022, global revenue for Diabetic Nephropathy reached approximately $2.37 billion, projected to grow at a 6.70% CAGR, hitting $4.86 billion by 2033. It holds a 2.0% revenue share in the…

<!-- Name:DistributionId Value:8754537 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Pune, Jan. 06, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Diabetic Nephropathy Market by Drug Class (Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers, Sodium Glucose…